Atlas Trials

BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Clinical trial NCT01672671 · COMPLETED

Trial details

NCT number
NCT01672671
Sponsor
Russian Academy of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Early Triple Negative Breast Cancer
Start date
2011-08-01
Primary completion
2015-06-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.